4.49
price down icon4.26%   -0.20
pre-market  Vorhandelsmarkt:  4.49  
loading
Schlusskurs vom Vortag:
$4.69
Offen:
$4.65
24-Stunden-Volumen:
862.14K
Relative Volume:
0.74
Marktkapitalisierung:
$326.56M
Einnahmen:
$195.82M
Nettoeinkommen (Verlust:
$-88.78M
KGV:
-1.7896
EPS:
-2.5089
Netto-Cashflow:
$-88.86M
1W Leistung:
-1.10%
1M Leistung:
-25.66%
6M Leistung:
+8.72%
1J Leistung:
-26.63%
1-Tages-Spanne:
Value
$4.47
$4.665
1-Wochen-Bereich:
Value
$4.39
$4.84
52-Wochen-Spanne:
Value
$3.4216
$7.20

Aurora Cannabis Inc. Stock (ACB) Company Profile

Name
Firmenname
Aurora Cannabis Inc.
Name
Telefon
-
Name
Adresse
10355 Jasper Avenue, Suite 500, Edmonton, AB
Name
Mitarbeiter
0
Name
Twitter
@Aurora_MMJ
Name
Nächster Verdiensttermin
2025-06-18
Name
Neueste SEC-Einreichungen
Name
ACB's Discussions on Twitter

Vergleichen Sie ACB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
ACB
Aurora Cannabis Inc.
4.49 326.56M 195.82M -88.78M -88.86M -2.5089
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
14.75 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
154.96 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.96 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.68 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.40 20.17B 16.54B -1.64B 749.00M -1.45

Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-11 Eingeleitet TD Cowen Buy
2024-02-09 Hochstufung Canaccord Genuity Hold → Buy
2022-09-21 Hochstufung Canaccord Genuity Sell → Hold
2022-06-24 Hochstufung Cantor Fitzgerald Neutral → Overweight
2022-06-06 Hochstufung Stifel Sell → Hold
2021-09-28 Hochstufung MKM Partners Sell → Neutral
2021-09-03 Hochstufung Jefferies Underperform → Hold
2021-05-14 Hochstufung BMO Capital Markets Underperform → Market Perform
2021-05-14 Herabstufung Canaccord Genuity Hold → Sell
2021-05-11 Herabstufung CIBC Neutral → Sector Underperform
2021-04-28 Fortgesetzt BofA Securities Neutral
2021-02-12 Herabstufung Desjardins Hold → Sell
2021-02-12 Herabstufung MKM Partners Neutral → Sell
2021-02-12 Herabstufung Needham Hold → Underperform
2020-12-18 Herabstufung BMO Capital Markets Market Perform → Underperform
2020-11-16 Herabstufung Jefferies Hold → Underperform
2020-11-11 Herabstufung Stifel Hold → Sell
2020-10-27 Herabstufung Cantor Fitzgerald Overweight → Neutral
2020-09-21 Hochstufung Jefferies Underperform → Hold
2020-09-08 Herabstufung Ladenburg Thalmann Buy → Neutral
2020-06-24 Hochstufung Stifel Sell → Hold
2020-05-22 Herabstufung Jefferies Hold → Underperform
2020-05-15 Hochstufung Piper Sandler Underweight → Neutral
2020-02-27 Herabstufung Bryan Garnier Neutral → Sell
2020-02-25 Eingeleitet Needham Hold
2020-02-24 Herabstufung Cowen Outperform → Market Perform
2020-02-14 Hochstufung MKM Partners Sell → Neutral
2020-02-07 Herabstufung Canaccord Genuity Speculative Buy → Hold
2020-01-10 Herabstufung BofA/Merrill Neutral → Underperform
2020-01-10 Herabstufung Piper Sandler Overweight → Neutral
2019-12-23 Herabstufung Jefferies Buy → Hold
2019-11-15 Hochstufung Cantor Fitzgerald Neutral → Overweight
2019-11-05 Eingeleitet Cantor Fitzgerald Neutral
2019-09-24 Eingeleitet CIBC Neutral
Alle ansehen

Aurora Cannabis Inc. Aktie (ACB) Neueste Nachrichten

pulisher
Jul 13, 2025

(ACB) Pivots Trading Plans and Risk Controls (ACB:CA) - news.stocktradersdaily.com

Jul 13, 2025
pulisher
Jul 12, 2025

Aurora Cannabis Inc. (TSE:ACB) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny - simplywall.st

Jul 12, 2025
pulisher
Jul 10, 2025

Aurora Cannabis Announces Shareholder Meeting Details - The Globe and Mail

Jul 10, 2025
pulisher
Jul 09, 2025

Aurora Cannabis announces annual shareholder meeting details - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Aurora Cannabis Inc. Announces Filing and Mailing of the Managem - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Aurora Cannabis files shareholder meeting materials ahead of august vote - StreetInsider

Jul 09, 2025
pulisher
Jul 09, 2025

Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders - PR Newswire

Jul 09, 2025
pulisher
Jun 27, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc.ACB - PR Newswire

Jun 27, 2025
pulisher
Jun 26, 2025

Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program - PR Newswire

Jun 26, 2025
pulisher
Jun 24, 2025

Premium 29% THC Medical Cannabis: Aurora Breaks Potency Records in Polish Market Launch - Stock Titan

Jun 24, 2025
pulisher
Jun 20, 2025

Aurora Cannabis Inc. (NASDAQ:ACB) Q4 2025 Earnings Call Transcript - Insider Monkey

Jun 20, 2025
pulisher
Jun 19, 2025

Aurora Cannabis says there is no truth to articles written with AI and published on investing site - The Globe and Mail

Jun 19, 2025
pulisher
Jun 19, 2025

Aurora Cannabis Inc (ACB) (Q4 2025) Earnings Call Highlights: Re - GuruFocus

Jun 19, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Reports Record Revenue and Growth - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis denies news of acquisition of New Zealand’s Medleaf Therapeutics - StratCann

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Refutes MedLeaf Acquisition Rumors - mg Magazine

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis announces new strategic partnership - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis (ACB) Denies Acquisition of MedLeaf Therapeutics - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis denies acquisition of MedLeaf Therapeutics - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis (ACB) Refutes Acquisition Rumors of MedLeaf Therapeutics | ACB Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics | ACB Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis (ACB) Denies News of Acquisition of MedLeaf Therapeutics - StreetInsider

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Denies News Of Acquisition Of MedLeaf Therapeutics - Barchart.com

Jun 18, 2025
pulisher
Jun 18, 2025

Cannabis Stock Movers For June 18, 2025 - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Q4 2025 Earnings Call Transcript - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade) (ACB) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis CEO touts ‘pristine’ balance sheet, but shares tumble - BNN Bloomberg

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis pays $215 million to acquire MedLeaf Therapeutics - MJBizDaily

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis (ACB) Reports Significant Q4 Revenue Growth - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Inc. - Baystreet.ca

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis (ACB) Shares Tumble After Earnings Report | ACB Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis (ACB) Shares Drop Despite Exceeding Revenue Expe - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis drops despite Q4 beat amid concerns over international growth - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis (ACB) Eyes First Profitable Year Amid Sector Cha - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter - Placera.se

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Q4 Loss Narrows, Adj.EBITDA Surges; Sees Sequentially Weak Demand In Q1; Stock Drops - Nasdaq

Jun 18, 2025
pulisher
Jun 18, 2025

ACB Projects Slight Dip in Q1 Revenue with Positive Cash Flow Ou - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Q4 FY25 slides: positive cash flow achieved amid global expansion - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis Files Full Year Results and Announces Fiscal 202 - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aurora Cannabis (ACB) Reports Strong Q4 Adjusted EBITDA Growth | ACB Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

ACB in charts: Q4 revenue from medical cannabis, plant propagation climb, consumer segment down - Seeking Alpha

Jun 18, 2025

Finanzdaten der Aurora Cannabis Inc.-Aktie (ACB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$14.90
price down icon 0.93%
$9.12
price down icon 1.41%
$133.46
price down icon 1.08%
$295.52
price down icon 1.55%
drug_manufacturers_specialty_generic RDY
$14.51
price down icon 1.09%
$16.40
price down icon 0.79%
Kapitalisierung:     |  Volumen (24h):